US Stock MarketDetailed Quotes

WST West Pharmaceutical Services

Watchlist
  • 307.210
  • -7.280-2.31%
Close Nov 18 16:00 ET
  • 306.900
  • -0.310-0.10%
Pre 05:02 ET
22.25BMarket Cap45.58P/E (TTM)

About West Pharmaceutical Services Company

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Company Profile

SymbolWST
Company NameWest Pharmaceutical Services
Listing DateJun 1, 1982
Issue Price16.00
Founded1923
CEOMr. Eric Mark Green
MarketNYSE
Employees10600
Fiscal Year Ends12-31
Address530 Herman O. West Drive
CityExton
ProvincePennsylvania
CountryUnited States of America
Zip Code19341-0645
Phone1-610-594-2900

Company Executives

  • Name
  • Position
  • Salary
  • Eric Mark Green
  • Chief Executive Officer, President and Chairman of the Board
  • 9.40M
  • Cindy Reiss-Clark
  • Chief Commercial Officer
  • 1.53M
  • Chad R. Winters
  • Vice President, Chief Accounting Officer and Corporate Controller
  • --
  • Bernard J. Birkett
  • Senior Vice President, Chief Financial and Operations Officer
  • 3.64M
  • Annette F. Favorite
  • Senior Vice President and Chief Human Resources Officer
  • --
  • Silji Abraham
  • Senior Vice President and Chief Technology Officer
  • 1.67M
  • Kimberly Banks MacKay
  • Senior Vice President, General Counsel and Corporate Secretary
  • 1.49M
  • Quintin J. Lai
  • Vice President, Strategy and Investor Relations
  • --
  • Robert F. Friel
  • Independent Director
  • 330.66K
  • Dr. Myla P. Lai-Goldman,M.D.
  • Independent Director
  • 359.35K
  • Deborah L.V. Keller
  • Independent Director
  • 333.45K
  • Thomas W. Hofmann
  • Independent Director
  • 390.35K
  • Paolo Pucci
  • Lead Independent Director
  • 367.44K
  • Dr. William F. Feehery, PhD
  • Independent Director
  • 362.83K
  • Dr. Stephen H. Lockhart, PhD
  • Independent Director
  • 331.46K
  • Molly E. Joseph
  • Independent Director
  • 321.43K
  • Douglas A. Michels
  • Independent Director
  • 377.01K
  • Mark A. Buthman
  • Independent Director
  • 378.23K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data